Transaction · 0002151678-26-000007

Rachlin Evan Lockwood

Rachlin Evan Lockwood, DIR, reported a transaction classified as unknown at Iambic Therapeutics, Inc. involving 410762.000000 shares. Reported holdings after the transaction were 1869498.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code CDIR
IAMIambic Therapeutics, Inc.
Trade date
Oct 16, 2026
Filing date
Oct 19, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded410kPrice unknown
Holdings after1.86MIndirect · See footnote
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

IAM price since this filing

Daily closing prices, with the filing date and available return windows
IAM · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
unknown
Code C
Identifier
0002151678-26-000007
Common Stock
Transaction date
Oct 16, 2026
Filed Oct 19, 2026, 11:47 PM · 3d delay
Shares
410,762 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
1,869,498 sh
Indirect · See footnote
Filing-only score

-8 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common…

  2. F2

    Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Comm…

  3. F3F5(2 footnotes)

    The shares are held of record by Ascenta Capital Fund I, L.P., or Ascenta Capital Fund I. As a Managing Member of Ascenta Capital Fund I, G.P., L.L.C., the General Partner of Ascenta Capital Fund I, t…

  4. F4

    The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).

Original filing · 0002151678-26-000007
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

IAM